News

Eli Lilly Beats Q1 Profit Estimates on Strength of Diabetes Drug
FILE PHOTO: Vials of Eli Lilly's Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and weight loss, ...
Eli Lilly Revenue Up on Demand for Mounjaro, Other Weight-Loss Meds
Eli Lilly revenue surged in the latest quarter on steady sales of Mounjaro and other weight-loss treatments in its portfolio.
Why Eli Lilly Stock Is Sinking Today
Shares of Eli Lilly ( LLY -10.79%) are sliding on Thursday. The stock lost 8.3% as of 12:21 p.m. ET. The leg down comes as ...
Eli Lilly CEO says tariffs are not the answer, urges Trump to move fast on trade deals
Eli Lilly CEO Dave Ricks took a stand against Trump's tariffs in a Q1 earnings call. The medicine company has strong operations for obesity and weight loss drugs in Ireland.
Eli Lilly CEO waves off CVS-Novo Nordisk deal: 'It feels a little like last decade'
But Eli Lilly CEO David Ricks waved off the deal Thursday, telling Yahoo Finance in an interview that the company is focused ...
Eli Lilly's Stock Is Up 15% This Year, and Here's Why It Could Take Off Even More
Growth stocks often don't come cheap, especially when their prospects look great, as is the case with Eli Lilly ( LLY 1.09%).
Stock Movers: Kohl's, Eli Lilly, Microsoft
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
Eli Lilly CEO Urges Trump to Ease Up on Tariffs, Extend 2017 Tax Cuts
The head of drugmaker Eli Lilly, which sells the popular weight-loss drug Zepbound, urged the Trump administration to ease up on its [tariff rollout]( ...
Eli Lilly’s worst day in nearly 17 years: Strategist Jared Holz on Q1 results
Jared Holz, Mizuho Securities health care strategist, joins 'Fast Money' to discuss Eli Lilly's biggest day drop since 2008 ...
Stock Movers: Meta, Eli Lilly, Kohl's
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...